OLIG2 and neoplasm: Furthermore, despite utilizing different approaches and driver mutations to induce tumor formation, the loss of NFIA or OLIG2 was also accompanied by significant decreases in tumor cell proliferation resulting in an increase in survival for their respective mouse models (Glasgow et al., 2017; Lu et al., 2016).